Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7904-7911

  Smiley, Stephen T ^a   Lanthier, Paula A ^a   Couper, Kevin N ^a   Szaba, Frank M ^a   Boyson, Jonathan E ^b   Chen, Wangxue ^c   Johnson, Lawrence L ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 12P40; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; ILEUM; IMMUNE DEFICIENCY; INFECTION RESISTANCE; LIVER; LUNG; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PRIORITY JOURNAL; PROTOZOAL INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; WEIGHT REDUCTION;

EID: 20444375877     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7904     Document Type: Article

References (80)

1. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microb. Rev. 11: 569-588.
2. Bliss, S. K., B. A. Butcher, and E. Y. Denkers. 2000. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 165: 4515-4521.
3. Bliss, S. K., L. C. Gavrilescu, A. Alcaraz, and E. Y. Denkers. 2001. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect. Immun. 69: 4898-4905.
4. Sayles, P. C., and L. L. Johnson. 1997. Exacerbation of toxoplasmosis in neutrophil-depleted mice. Nat. Immun. 15: 249-258.
5. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115-6119.
6. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153: 2533-2543.
7. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84: 16-20.
8. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells: a role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 155: 4347-4354.
9. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of γ-interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor-α. Infect. Immun. 62: 2818-2824.
10. Johnson, L. L., and P. C. Sayles. 1995. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii. Nat. Immun. 14: 209-215.
11. + lymphocytes. Infect. Immun. 61: 5174-5180.
12. Sher, A., I. P. Oswald, S. Hieny, and R. T. Gazzinelli. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150: 3982-3989.
13. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
14. Suzuki, Y., F. K. Conley, and J. S. Remington. 1990. Treatment of toxoplasmic encephalitis in mice with recombinant γ-interferon. Infect. Immun. 58: 3050-3055.
15. Langermans, J. A., M. E. Van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. Van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148: 568-574.
16. Langermans, J. A., M. E. van der Hulst, P. H. Nibbering, and R. van Furth. 1992. Endogenous tumor necrosis factor-α is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant γ-interferon-treated mice. Infect. Immun. 60: 5107-5112.
17. Murray, H. W., and Z. A. Cohn. 1979. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J. Exp. Med. 150: 938-949.
18. Remington, J. S., and T. C. Merigan. 1968. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science 161: 804-806.
19. Remington, J. S., J. L. Krahenbuhl, and J. W. Mendenhall. 1972. A role for activated macrophages in resistance to infection with Toxoplasma. Infect. Immun. 6: 829-834.
20. + T cells but not inhibition of the protective activity of IFN-γ prevents cure of toxoplasmosis mediated by drag therapy in mice. J. Immunol. 149: 3003-3007.
21. +) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice. Infect. Immun. 59: 1614-1619.
22. + T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145: 3438-3441.
23. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149: 175-180.
24. + T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J. Immunol. 163: 4503-4509.
25. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152: 1856-1860.
26. + T cell subsets in protective immune responses of mice against infection with a low or high virulent strain of Toxoplasma gondii. Microbiol. Immunol. 35: 215-222.
27. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 84: 207-212.
28. + T lymphocytes are the major cell population involved in the early γ-interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiol. Immunol 38: 789-796.
29. + T cells in mice. J. Immunol. 140: 3943-3946.
30. Johnson, L. L., and P. C. Sayles. 2002. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect. Immun. 70: 185-191.
31. Kang, H., J. S. Remington, and Y. Suzuki. 2000. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J. Immunol. 164: 2629-2634.
32. Sayles, P. C., G. W. Gibson, and L. L. Johnson. 2000. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 68: 1026-1033.
33. + T cell-dependent interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184: 597-607.
34. Liesenfeld, O., H. Kang, D. Park, T. A. Nguyen, C. V. Parkhe, H. Watanabe, T. Abo, A. Sher, J. S. Remington, and Y. Suzuki. 1999. TNF-α, nitric oxide, and IFN-γ are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 21: 365-376.
35. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
36. Brossay, L., D. Jullien, S. Cardell, B. C. Sydora, N. Burdin, R. L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159: 1216-1224.
37. + T lymphocytes. Science 268: 863-865.
38. Van Rijn, I., D. C. Young, J. S. Im, S. B. Levery, P. A. Illarionov, G. S. Besra, S. A. Porcelli, J. Gumperz, T.-Y. Cheng, and D. B. Moody. 2004. CD1d-restricted T cell activation by nonlipidic small molecules. Proc. Natl. Acad. Sci. USA 101: 13578-13583.
39. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Uenon, R. Nakagawa, H. Sata, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of vα14NKT cells by glycosylceramides. Science 278: 1626-1629.
40. Schofield, L., M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S. D. Tachado. 1999. CD1d-restricted immunoglobulin G formation to GP1-anchored antigens mediated by NKT cells. Science 283: 225-229.
41. Duthie, M. S., M. Wleklinski-Lee, S. Smith, T. Nakayama, M. Taniguchi, and S. J. Kahn. 2002. During Trypanosoma cruzi infection CD1-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70: 36-48.
42. Amprey, J. L., J. S. Im, S. J. Turco, H. W. Murray, P. A. Illarionov, G. S. Besra, S. A. Porcelli, and G. F. Spath. 2004. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200: 895-904.
43. Molano, A., S.-H. Park, Y.-H. Chui, S. Nosseir, A. Bendelac, and M. Tsuji. 2000. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial response. J. Immunol. 164: 5005-5009.
44. Romero, J. F., G. Eberl, H. R. MacDonald, and G. Corradin. 2001. CD1d-restricted NKT cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice. Parasite Immunol. 23: 267-269.
45. Procopio, D. O., I. C. Almeida, A. C. C. Torrecilhas, J. E., L. Teyton, L. R. Travassos, A. Bendelac, and R. T. Gazzinelli. 2002. Glycophosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 169: 3926-3933.
46. - T cells in mice and humans. J. Exp. Med. 180: 1097-1106.
47. Behar, S. M., T. A. Podrebarac, C. J. Roy, C. R. Wang, and M. B. Brenner. 1999. Diverse TCRs recognize murine CD1. J. Immunol. 162: 161-167.
48. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182: 993-1004.
49. - T cells. J. Exp. Med. 186: 109-120.
50. Kawakami, K., Y. Kinjo, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito. 2001. Monocyte chemoattractant protein-1-dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167: 6525-6532.
51. Grubor-Bauk, B., A. Simmons, G. Mayrhofer, and P. Speck. 2003. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J. Immunol. 170: 1430-1434.
52. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77: 10168-10171.
53. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33: 3322-3330.
54. + effector function against intracellular infection. J. Exp. Med. 184: 131-139.
55. + T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection. Biochem. Soc. Trans. 25: 699-703.
56. Smiley, S. T., M. H. Kaplan, and M. J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275: 977-979.
57. Exley, M. A., N. J. Bigley, O. Cheng, A. Shaulov, S. M. A. Tahir, Q. L. Carter, J. Garcia, C. Wang, K. Patten, H. F. Stills, et al. 2003. Innate immune response to encephalomyocarditis infection mediated by CD1d. Immunology 110: 519-526.
58. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
59. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95: 5690-5693.
60. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76: 4294-4303.
61. Nieuwenhaus, E. E. S., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593.
62. Kumar, H., A. Belperron, S. W. Barthold, and L. K. Bockenstedt. 2000. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165: 4797-4801.
63. Arrunategui-Correa, V., and H. S. Kim. 2004. The role of CD1d in the immune response against Listeria infection. Cell. Immunol. 227: 109-120.
64. Hansen, D. S., M.-A. Siomos, L. Buckingham, A. A. Scalzo, and L. Schofield. 2003. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18: 391-402.
65. Hansen, D. S., M. A. Siomos, T. de Koning-Ward, L. Buckingham, B. S. Crabb, and L. Schofield. 2003. CD1d-restricted NKT cells contribute to malarial spenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 33: 2588-2593.
66. Johnson, L. L. 1992. SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections. Infect. Immun. 60: 3719-3724.
67. Johnson, L. L., P. Lanthier, J. Hoffman, and W. Chen. 2004. Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii. Vaccine 22: 4054-4061.
68. Kasper, L. H., M. S. Bradley, and E. R. Pfefferkorn. 1984. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies. J. Immunol. 132: 443-449.
69. Johnson, L. L., K. N. Berggren, F. M. Szaba, W. Chen, and S. T. Smiley. 2003. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197: 801-806.
70. Gazzinelli, R. T., S. Hayashi, M. Wysocka, L. Carrera, R. Kuhn, W. Muller, F. Roberge, G. Trinchieri, and A. Sher. 1994. Role of 1L-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J. Eukaryot. Microbiol. 41: 9S.
71. Suzuki, Y., A. Sher, G. Yap, D. Park, L. E. Neyer, O. Liesenfeld, M. Fort, H. Kang, and E. Gufwoli. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164: 5375-5382.
72. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165: 3673-3679.
73. + T cells. J. Immunol. 164: 2009-2015.
74. Baron, J. L., L. Gardiner, S. Nishimura, K. Shinkai, R. Locksley, and D. Ganem. 2002. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16: 583-594.
75. Roberts, T. J., Y. Lin, P. M. Spence, L. Van Kaer, and R. R. Brutkiewicz. 2004. CD1d1-dependent control of the magnitude of an acute antiviral immune response. J. Immunol. 172: 3454-3461.
76. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
77. Bleicher, P. A., S. P. Balk, S. J. Hagen, R. S. Blumberg, T. J. Flotte, and C. Terhorst. 1990. Expression of murine CD1 on gastrointestinal epithelium. Science 250: 679-682.
78. Colgan, S. P., R. M. Hershberg, G. T. Furuta, and R. S. Blumberg. 1999. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 96: 13938-13943.
79. Buzoni-Gatel, D., H. Debbabi, F. J. D. Mennechet, V. Martin, A. C. Lepage, J. D. Schwartzman, and L. H. Kasper. 2001. Murine ileitis after intracellular parasite infection is controlled by TGF-β-producing intraepithelial lymphocytes. Gastroenterology 120: 914-924.
80. + thymocyte population associated with intact Fas expression on the target. J. Exp. Med. 180: 423-432.